Vijaya Diagnostic Centre Ltd

₹ 447 -1.27%
07 Dec - close price
About

Vijaya Diagnostics Centre limited is a leading diagnostic medicare services provider in Southern India and offers comprehensive services that include nuclear medicine, radiology, laboratory, health check-ups and medical services. The company provides its services across 13 cities through its 81 diagnostic centers and 11 reference laboratories.[1]

Key Points

Largest Diagnostic Chain in Southern India [1]
Vijaya Diagnostic Center Ltd. (VDCL) is the largest integrated diagnostic chain in southern India, by revenue and also one of the fastest-growing diagnostic chains by revenue for the FY20.

  • Market Cap 4,566 Cr.
  • Current Price 447
  • High / Low 602 / 292
  • Stock P/E 50.9
  • Book Value 49.0
  • Dividend Yield 0.22 %
  • ROCE 28.3 %
  • ROE 26.4 %
  • Face Value 1.00

Pros

  • Company has a good return on equity (ROE) track record: 3 Years ROE 25.9%

Cons

  • Stock is trading at 9.13 times its book value

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Healthcare Industry: Healthcare

Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Jun 2020 Sep 2020 Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022
52 113 100 112 123 113 111 116 104 121
38 62 53 58 66 62 63 68 64 72
Operating Profit 14 51 46 54 57 51 48 48 40 49
OPM % 27% 45% 46% 49% 46% 45% 43% 41% 38% 40%
2 2 3 4 3 3 3 3 3 3
Interest 4 4 4 3 4 4 4 4 5 5
Depreciation 12 14 12 13 12 12 13 15 14 16
Profit before tax 1 36 33 43 44 38 34 31 24 31
Tax % -181% 25% 25% 26% 25% 26% 25% 24% 26% 25%
Net Profit 2 27 25 32 33 28 25 24 18 23
EPS in Rs 3.99 58.30 54.57 6.93 3.23 2.72 2.48 2.33 1.71 2.29
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2019 Mar 2020 Mar 2021 Mar 2022 TTM
293 339 377 462 452
184 206 211 259 268
Operating Profit 108 133 166 204 184
OPM % 37% 39% 44% 44% 41%
10 15 12 13 12
Interest 14 15 15 16 18
Depreciation 40 49 50 53 58
Profit before tax 65 83 112 147 120
Tax % 29% 25% 24% 25%
Net Profit 46 63 85 111 90
EPS in Rs 101.29 138.00 18.64 10.76 8.81
Dividend Payout % -0% -0% -0% 9%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: 16%
TTM: 1%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: 34%
TTM: -23%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: -22%
Return on Equity
10 Years: %
5 Years: %
3 Years: 26%
Last Year: 26%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Sep 2022
5 5 5 10 10
Reserves 200 270 354 458 490
146 161 141 183 230
56 46 41 62 69
Total Liabilities 406 482 541 713 799
259 272 268 370 487
CWIP 3 10 9 34 9
Investments 69 55 28 54 84
76 146 236 255 220
Total Assets 406 482 541 713 799

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2019 Mar 2020 Mar 2021 Mar 2022
91 106 130 158
-90 -31 -130 -123
-7 -30 -49 -31
Net Cash Flow -6 46 -49 4

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2019 Mar 2020 Mar 2021 Mar 2022
Debtor Days 11 9 6 8
Inventory Days 20 23 17 22
Days Payable 196 180 142 110
Cash Conversion Cycle -165 -149 -118 -81
Working Capital Days -40 -38 -15 -23
ROCE % 24% 27% 28%

Shareholding Pattern

Numbers in percentages

2 recently
Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022
54.78 54.78 54.78 55.04 55.01
23.36 26.37 28.12 27.99 23.89
15.89 14.97 13.08 12.81 15.77
5.97 3.88 4.02 4.16 5.33

* The XBRL reporting format changed from Sep'2022 onwards. The new format added details about banks and foreign portfolio investors. These were not available earlier.
The sudden increase in FII or DII might be because of these changes.

Please click on the line-items to see the names of individual entities.

Documents